panitumumab
amgen,takeda
['panitumumab', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'paradigm']
panitumumab + mfolfox6 in 1l for pts. with ras wild-type and left-sided mcrc - paradigm trail #asco22 great discussion by 
Molecular Precision Oncology ?? #CovidCancerVisionProject Molecular Precision Medicine @MedUni_Wien